These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35335086)

  • 21. Diabetic ketoacidosis and hyperosmolar hyperglycemic state.
    Gouni-Berthold I; Krone W
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():100-5. PubMed ID: 16802531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study.
    Pasquel FJ; Tsegka K; Wang H; Cardona S; Galindo RJ; Fayfman M; Davis G; Vellanki P; Migdal A; Gujral U; Narayan KMV; Umpierrez GE
    Diabetes Care; 2020 Feb; 43(2):349-357. PubMed ID: 31704689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Case of New Onset Diabetes and Severe Diabetes Ketoacidosis in a Patient With COVID-19.
    Patel L; Ayad S; Rayad MN; Gergis K; Ejikeme C; Talpur A; Abdelazeem B; Eckman A
    Cureus; 2021 Aug; 13(8):e16923. PubMed ID: 34513494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19].
    Ma WX; Ran XW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 51(2):146-150. PubMed ID: 32220179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric Diabetic Ketoacidosis With Hyperosmolarity: Clinical Characteristics and Outcomes.
    Agrawal S; Baird GL; Quintos JB; Reinert SE; Gopalakrishnan G; Boney CM; Topor LS
    Endocr Pract; 2018 Aug; 24(8):726-732. PubMed ID: 30084686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicentre analysis of hyperglycaemic hyperosmolar state and diabetic ketoacidosis in type 1 and type 2 diabetes.
    Tittel SR; Sondern KM; Weyer M; Poeplau T; Sauer BM; Schebek M; Ludwig KH; Hammer F; Fröhlich-Reiterer E; Holl RW;
    Acta Diabetol; 2020 Oct; 57(10):1245-1253. PubMed ID: 32488499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of age on the presentation and outcome of acidotic and hyperosmolar diabetic emergencies.
    MacIsaac RJ; Lee LY; McNeil KJ; Tsalamandris C; Jerums G
    Intern Med J; 2002 Aug; 32(8):379-85. PubMed ID: 12162394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for adverse outcomes in children with diabetic ketoacidosis.
    Yousif MF; Dolak KD; Adhikari S; White PC
    J Clin Endocrinol Metab; 2024 Jul; ():. PubMed ID: 39031569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic ketoacidosis and hyperglycemic hyperosmolar state.
    Maletkovic J; Drexler A
    Endocrinol Metab Clin North Am; 2013 Dec; 42(4):677-95. PubMed ID: 24286946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 and Combined Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Nonketotic Coma: Report of 11 Cases.
    Singh B; Kaur P; Majachani N; Patel P; Reid RR; Maroules M
    J Investig Med High Impact Case Rep; 2021; 9():23247096211021231. PubMed ID: 34088220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe complications after initial management of hyperglycemic hyperosmolar syndrome and diabetic ketoacidosis with a standard diabetic ketoacidosis protocol.
    Nambam B; Menefee E; Gungor N; Mcvie R
    J Pediatr Endocrinol Metab; 2017 Oct; 30(11):1141-1145. PubMed ID: 28988226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 Vaccination and Its Relation to New-Onset Diabetes: A Narrative Review.
    Sivaprakasam DR; Ohiri HO; Asif MS; Jahangir MS; Khan MKG; Nabeel MA; Abdullah RM
    Cureus; 2023 Oct; 15(10):e47056. PubMed ID: 38022276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin and glucagon ratio in the patho-physiology of diabetic ketoacidosis and hyperosmolar hyperglycemic non-ketotic diabetes.
    Wahid M; Naveed AK; Hussain I
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):11-4. PubMed ID: 16441980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations.
    Palermo NE; Sadhu AR; McDonnell ME
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32556147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity in presentation of hyperglycaemia during COVID-19 pandemic: A proposed classification.
    Misra A; Ghosh A; Gupta R
    Diabetes Metab Syndr; 2021; 15(1):403-406. PubMed ID: 33588198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Hyperglycemia and Diabetes in the Emergency Department.
    Echouffo-Tcheugui JB; Garg R
    Curr Diab Rep; 2017 Aug; 17(8):56. PubMed ID: 28646357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: a Literature Review.
    Tilinca MC; Gliga MC; Varga A
    J Crit Care Med (Targu Mures); 2022 Jan; 8(1):6-13. PubMed ID: 35274050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients.
    Subbaram K; Ali PSS; Ali S
    Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA).
    Dhatariya KK; Vellanki P
    Curr Diab Rep; 2017 May; 17(5):33. PubMed ID: 28364357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.